Influenza HA vaccine was inoculated to patients with chronic renal failure [hemodialysis (HD) group 49, peritoneal dialysis (PD) group 17, under conservative treatment (conservative) group 22] and the healthy subjects (control) group 29, and the following results were obtained:
1) Degrees of increase in the geometric mean hemagglutinin inhibition (HI) titer, increase in numbers of cases who had HI titer of 64X or more, and 4X or more increase in the HI titer to the antigens contained in the vaccine, A/Kumamoto/37/79 (H1N1), A/Ishikawa/7/82 (H3N2) and B/Singapore/222/79 were comparably well in the HD, PD and conservative and the control groups.Comparing the various antigens contained in the vaccine, increase in the HI titer was better with A/Kumamoto/37/79 (H1N1), A/Ishikawa/7/82 (H3N2) than with B/Singapore/222/79 in the control, HD, PD and conservative groups.
2) Among drifted antigens of A (H3N2), increase in the HI titer responded to A/Kyoto/C-1/81 was significantly less in the HD, PD and conservative groups than in the control group, and increase in the HI titer responded to A/Niigata/102/81 was significantly less in the HD group than in the control group. Therefore, it may be said that the HI titer to some drifted antigens was not increased in the patients with chronic renal failure in the HD, PD and conservative groups, while the healthy subjects showed significant increase of the HI titer.
3) No specific adverse reaction, local or systemic, due to the vaccination was observed both in the patients and the healthy subjects.
4) General conditions of the patients under treatments for chronic renal failure were not aggravated by the vaccination.
It may be conclusively considered from the above results that when adequate strains are selected as vaccine strains, desirable HI titer increase may be expected after the vaccination in the patients with chronic renal failure as in the healthy subjects.
The results may suggest that safe vaccination will be given to the patients with chronic renal failure considered as high risk group to influenza infection, and such safe vaccination should be performed more positively in order to protect the patients from infection to influenza.
View full abstract